Report interim data from the ATTENTION-AD open-label extension trial
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 9 May 2024
- Due
- 31 Dec 2024
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Ongoing ATTENTION-AD open-label extension 96-week trial. Interim data expected in the second half of 2024.”
What we found
Evidence strength A What the grades mean
The company explicitly stated in later filings that it did not plan to provide interim updates for the ATTENTION-AD trial, contrary to its previous commitment to report interim data in 2024.
-
A Anavex Life Sciences Corp. 10-Q filed 2025-05-13
“The Company plans to announce the results when the EMA review and decision-making is finished and does not plan to provide interim updates.” ✓ confirmed on the page
Market reaction: the shares moved -3.4% against the S&P 500 over the three sessions around the disclosure (12 May 2025 to 15 May 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Interim trial data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: disagreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and read it as “no_evidence”, so a person decides.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Anavex Life Sciences Corp.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-AVXL-002465 · Corrections policy